Tuune provides individualized hormonal analysis and personalized birth control recommendations through proprietary technology used by its clinicians. The company combines comprehensive health history, lifestyle preferences, and hormone analysis to recommend birth control tailored to alleviate symptoms and conditions such as endometriosis, anxiety, weight gain, and acne. Tuune says its first product educates and empowers women to choose the right birth control for their unique hormones and biology. The $4.6M fundraising will support Tuune’s launch in the U.S. market and efforts to build an individualized medical system that centers hormones. The team includes experts in precision medicine, science, and engineering and is backed by prominent organizations including Google for Startups. Co-founder Shardi Nahavandi, motivated by a personal misdiagnosis and hormonal imbalance, is a public face of the company’s advocacy for better hormonal healthcare; women can apply for early access at www.tuune.com.

Total raised

$5M

Funding rounds

1

Latest round

Equity

Latest activity

Oct 2021